4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000085
EVP, Global Research and CSO sold 3,002 shares at $421.77 ($1,266,154)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ALTSHULER DAVID · EVP, Global Research and CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-21 | Sale : show line 1 in the form 10b5-1 | −3,002 | $421.77 | $1,266,154 | 34,022 | D |
| Open-market sales · 3,002 sh · avg $421.77 · $1,266,154 | ||||||
Loading xslF345X05/wk-form4_1708722602.xml…